Physician profile
Adnan Ejupovic
NPI 1588283006
$4,142.24
in general payments reported to CMS, 2019-2025
7 companies · $49.25 in 2025
The $49.25 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $3,658 · 2023: $415 · 2024: $20.04 · 2025: $49.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $484.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $483.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rock Medical Orthopedics, INC. | $3,600.00 | 2022 | |
| Orthofix Medical, INC. | $147.72 | 2023 | Physio-Stim, Truelok System |
| Kerecis Limited | $137.76 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Paragon 28, INC. | $98.94 | 2023 | Portfolio, Phantom Metatarsal Shortening |
| Stryker Corporation | $88.53 | 2022-2023 | Ortholoc 2 Lapifuse, Prophecy |
| Mimedx Group, INC. | $37.52 | 2024-2025 | |
| Depuy Synthes Sales INC. | $31.77 | 2025 | Na |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adnan Ejupovic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.